Skip to content

SCREENER CHART SD50 CALENDAR NEWS

...

Azitra, Inc. (AZTR) Stock · SELL · CRISIS | LOPJLB

Azitra, Inc. (AZTR)

Healthcare · Biotechnology · AMEX · US

$0.13+0.00%Close

SELLCRISIS · day 9

AZTR▼ SELL

$0.13+0.00%

Overview FinancialsFin EarningsEarn Analyst & RatingsAnalyst News Holders & ETFsHold Options

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $1M
Beta: -1.04
P/E (TTM): -0.10

Short % float: 2.36%
Days to cover: 1.0
SI change: -65.7%

1W: +0.00%
1M: -27.78%

vs SPY 1W: -1.16%
vs SPY 1M: -30.77%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Azitra, Inc. is a pre-clinical biopharmaceutical company focused on developing precise treatments for various dermatological conditions. They innovate by utilizing engineered proteins and live biotherapeutic products to address skin diseases. The company's pipeline features…

Employees: 13
Headquarters: US
Founded: 2023
Exchange: AMEX
Sector: Healthcare
Industry: Biotechnology
Shares out: 10.7M
Float: 94.9%

azitrainc.com ↗

Key executives

Francisco D. Salva — President, Chief Executive Officer & Director

Norman Staskey — Chief Financial Officer & Treasurer

Travis Whitfill — Co-Founder, Chief Operating Officer, Secretary & Director

SEC filings

EDGAR · CIK 17014780 · AZTR

All filings
10-K
10-Q
8-K
Form 4

Analyst consensus

Buy

Bullish1100.0%

Neutral00.0%

Bearish00.0%

Last$0.13

Company news

prnewswire.com · 9d ago

Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance

defenseworld.net · 11d ago

Azitra, Inc. (NYSEAMERICAN:AZTR) Sees Significant Drop in Short Interest

prnewswire.com · 32d ago

Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference

prnewswire.com · 50d ago

Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards

prnewswire.com · 59d ago

Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates

prnewswire.com · 87d ago

Azitra, Inc. Announces Breakthough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Increased Distribution and Elasticity

Market news & ticker search · RSS for AZTR

LOPJLB

Independent quant research on U.S. equities & ETFs. Not personalized advice.

Product

Screener Chart Compare SD50 Thesis News Calendar

Desk

Market Heatmap Market Hours FOMC Desk Treasury Rates Congress Trades Prediction Markets

Research

How It Works Methodology Track Record Editorial Blog Changelog

Ledgers

Bull Spreads Cash-Secured Puts Covered Calls Long Puts Long Calls

Screeners

CEF Screener REIT Screener BDC Screener Preferred Screener Dividend Screener ETF Screener Crypto Screener S&P 500 Screener

Company

Pricing About Contact

Agents

GitHub·Research Chat·MCPENT·Developers

© 2026 LOPJLB Research. All rights reserved.

@lopjlb contact@lopjlb.com

RANGE

LOPJLB.COM

OHLC🔒EMALEVELS🔒STOP🔒FLIP🔒52WSIGNALS🔒BUY🔒SELL🔒EXH🔒EXH ZONE